BioAge Labs, Inc. share price logo

BioAge Labs, Inc.

NASDAQ: BIOA

Small Cap

$8.06

-0.03

(-0.37%)

as on

BioAge Labs, Inc. Stock Performance

as on September 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $7.86
    $8.23
    downward going graph

    2.48%

    Downside

    2.11%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.88
    $25.96
    downward going graph

    39.49%

    Downside

    222.02%

    Upside

    downward going graph

BioAge Labs, Inc. share price movements today

Previous Close
$8.09
Open
$8.01
Volume
550.1K
Market Cap
$355.7M
Day's Low - High
$7.86 - $8.23
52 Week Low - High
$4.88 - $25.96

BioAge Labs, Inc. Historical Returns

1 Month Return
-24.74 %
3 Month Return
-61.05 %
1 Year Return
+ 65.1 %
3 Year Return
0 %
5 Year Return
0 %

BioAge Labs, Inc. Stock Fundamentals & Key Indicators

Check BioAge Labs, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$355.7M

EPS (TTM)

-2.38

Dividend Yield

0.00%

PE Ratio (TTM)

-3.44

Industry PE ratio

2.29

PEG Ratio

0.4638438161405056

Return On Equity TTM

-28.99%

BioAge Labs, Inc. Stock Valuation

Track how BioAge Labs, Inc. P/E has moved over time to understand its valuation trends.

BioAge Labs, Inc. in the last 4 years

  • Overview

  • Trends

Lowest (-5.91x)

December 31, 2025

Today (-5.91x)

December 31, 2025

Industry (2.29x)

December 31, 2025

Highest (-2.14x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -5.91x

BioAge Labs, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioAge Labs, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BioAge Labs, Inc. image
BioAge Labs, Inc.
StrongBuy$355.7MNA-3.4499.39%0.00%
United Therapeutics image
United Therapeutics
BUY$21.3B148.54%16.5586.14%0.00%
Viatris image
Viatris
HOLD$19.1B26.23%-47.5834.83%2.82%
Haleon PLC Sponsored ADR image
Haleon PLC Sponsored ADR
BUY$40.0BNA18.7765.57%1.35%
Zoetis image
Zoetis
BUY$30.3B-63.21%12.0170.87%2.86%
See all

Stock Returns calculator for BioAge Labs, Inc. Stock including INR - Dollar returns

The BioAge Labs, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 10Y

BioAge Labs, Inc. investment value today

Current value as on today

₹1,79,016

Returns

₹79,016

(+79.02%)

Returns from BioAge Labs, Inc. Stock

₹64,490 (+64.49%)

Dollar Impact

₹14,526 (+14.53%)

Analyst Recommendation on BioAge Labs, Inc. Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.77777777777779% of analysts recommend a 'BUY' rating for BioAge Labs, Inc.. Average target price of $35.625

Indian Investors' Interest in BioAge Labs, Inc. Stock

Search interest for BioAge Labs, Inc. Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-42% versus previous 30 day period

BioAge Labs, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
1
2
2
3
2
2
Gross Profit
-
-
-
-
1
2
2
3
2
2
Operating Income
-12
-15
-24
-25
-16
-24
-23
-28
-25
-29
EBITDA
-11
-13
-22
-20
-12
-21
-19
-25
-22
-26
Interest Expense
1
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-13
-23
-21
-12
-21
-20
-25
-22
-26
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-12
-13
-23
-21
-12
-21
-20
-25
-22
-26
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
100.00%
100.00%
100.00%
100.00%
97.73%
100.00%

BioAge Labs, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
8
Gross Profit
-
-
-
8
Operating Income
-39
-48
-78
-92
EBITDA
-39
-55
-68
-79
Interest Expense
0
7
2
0
Depreciation
0
0
0
0
Income Before Tax
-39
-63
-71
-80
Income Tax Expense
-
-
-
-
Net Income
-39
-63
-71
-80
Net Profit Margin
0.00%
0.00%
0.00%
100.00%

BioAge Labs, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-12
-13
-23
-21
-12
-21
-20
-25
-22
-26
Operating Cash Flow
-15
-15
-14
-5
-17
-19
-16
-28
-24
-19
Investing Cash Flow
-
0
0
0
-77
-15
12
-14
-46
-164
Financing Cash Flow
168
-2
190
24
-1
-1
-1
16
123
15
Change in Cash
152
-18
175
19
-96
-37
-4
-26
52
-167

BioAge Labs, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-39
-63
-71
-80
Operating Cash Flow
-36
-37
-51
-81
Investing Cash Flow
0
0
0
-95
Financing Cash Flow
2
34
381
11
Change in Cash
-33
-2
329
-165

Mutual Funds that own BioAge Labs, Inc. Stock

Check out the Mutual Funds with significant holdings in BioAge Labs, Inc..

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.879762%
1321722
Fidelity Salem Street Trust
0.742777%
340912
Fidelity Concord Street Trust
0.59575%
273431
VANGUARD SCOTTSDALE FUNDS
0.298261%
136893
DFA INVESTMENT DIMENSIONS GROUP INC
0.226982%
104178
See all

Global Institutional Holdings in BioAge Labs, Inc.

Funds
Holdings
Vanguard
4.13%
iShares
4.05%
Peter Kolchinsky
3.64%
SPDR
1.17%
Fidelity
0.51%
See all

Insights on BioAge Labs, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 71.2% return, outperforming this stock by 6.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, BIOA stock has moved down by -25.0%

About BioAge Labs, Inc.

BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
OrganisationBioAge Labs, Inc.
Headquarters5885 Hollis Street, Emeryville, CA, 94608, US
IndustryBiotechnology
CEOKristen Fortney
E-voting on sharesClick here to vote

Key Management of BioAge Labs, Inc.

Name

Title

Dr. Paul D. Rubin M.D.

Chief Medical Officer & Executive VP of Research

Ms. Julie Gammelgard

Senior Vice President of People

Mr. BJ Sullivan Ph.D.

Chief Strategy Officer

Dr. Kristen Fortney Ph.D.

Co-Founder, CEO, President, Treasurer, Secretary & Director

Dr. Eric Morgen M.D.

Co-Founder, COO & Director

Dr. Dov A. Goldstein M.B.A., M.D.

Chief Financial Officer

Mr. Shane Barton CPA

Senior Vice President of Finance & Accounting

Mr. Rusty Montgomery Ph.D.

Senior Vice President of Research

Dr. Peng Leong M.B.A., Ph.D.

Chief Business Officer & Therapeutic Area Head of Brain Aging

Ms. Ann C. Neale RN BSN

Chief Development Officer

FAQs

What is BioAge Labs, Inc. share price today?

BioAge Labs, Inc. share price today is $8.06 as on at the close of the market. BioAge Labs, Inc. share today touched a day high of $8.23 and a low of $7.86.

What is the 52 week high and 52 week low for BioAge Labs, Inc. share?

BioAge Labs, Inc. share touched a 52 week high of $25.96 on and a 52 week low of $4.88 on . BioAge Labs, Inc. stock price today i.e. is closed at $8.06,which is 68.95% down from its 52 week high and 65.25% up from its 52 week low.

What is BioAge Labs, Inc.'s market capitalisation today?

BioAge Labs, Inc. market capitalisation is $0.00T as on .

How to invest in BioAge Labs, Inc. Stock (BIOA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for BioAge Labs, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BioAge Labs, Inc. Shares that will get you 0.1861 shares as per BioAge Labs, Inc. share price of $8.06 per share as on September 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy BioAge Labs, Inc. Stock (BIOA) from India?

Indian investors can start investing in BioAge Labs, Inc. (BIOA) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in BioAge Labs, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on BioAge Labs, Inc. share’s latest price of $8.06 as on September 19, 2026 at 8:45 am IST, you will get 1.2407 shares of BioAge Labs, Inc.. Learn more about fractional shares .